Testing effectiveness (Phase 2)Study completedNCT00590902
What this trial is testing
Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
Who this might be right for
Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 81